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ABSTRACT
Introduction Symptom perception in heart failure (HF) 
has been identified as crucial for effective self- care, and 
is related to patient and health system outcomes. There 
is uncertainty regarding the feasibility and acceptability of 
symptom perception support and doubts regarding how 
to include informal caregivers. This study aims to test the 
feasibility, acceptability and outcome responsiveness of 
an intervention supporting symptom perception in persons 
with HF and their informal caregiver.
Methods and analysis A feasibility study with a quasi- 
experimental pretest and post- test single group design 
is conducted. The convenience sample consists of 30 
persons with HF, their informal caregivers and six nurses. 
SYMPERHEART is an evidence- informed intervention that 
targets symptom perception by educational and support 
components. Feasibility is measured by time- to- recruit; 
time- to- deliver; eligibility rate; intervention delivery 
fidelity rate. Acceptability is measured by rate of consent, 
retention rate, treatment acceptability and the engagement 
in the intervention components. Outcome responsiveness 
includes: HF self- care (via the Self- care of Heart Failure 
Index V.7.2); perception of HF symptom burden (via the 
Heart Failure Somatic Perception Scale V.3); health status 
(via the Kansas City Cardiomyopathy Questionnaire-12); 
caregivers’ contribution to HF self- care (via the Caregiver 
Contribution to Self- Care of Heart Failure Index 2); 
caregivers’ burden (via the Zarit Burden Interview). Clinical 
outcomes include HF events, hospitalisation reason and 
length of hospital stay. Descriptive statistics will be used to 
report feasibility, acceptability, patient- reported outcomes 
(PRO) and clinical outcomes. PRO and caregiver- reported 
outcome responsiveness will be reported with mean 
absolute change and effect sizes.
Ethics and dissemination The study is conducted 
according to the Declaration of Helsinki. The Human 
Research Ethics Committee of the Canton of Vaud, 
Switzerland, has approved the study. Written informed 
consent from persons with HF and informal caregivers 
are obtained. Results will be published via peer reviewed 
and professional journals, and further disseminated via 
congresses.
Trial registration number ISRCTN18151041.
INTRODUCTION
The importance of heart failure self-care
Heart failure (HF) is a major health concern1 2 
related to poor quality of life,3 frequent hospi-
talisation and high mortality.4 5 HF self- care 
is recognised as an important contributor 
to improved outcomes in terms of reduced 
myocardial stress,6 reduced systemic inflam-
mation6 and event- free survival.7 8 While HF 
self- care support is recommended within 
modern treatment approaches including 
multidisciplinary management programs,2 
HF self- care remains suboptimal worldwide9 
as in the Swiss context.10 11 HF self- care is 
composed of three constructs occurring in 
sequence: self- care maintenance, symptom 
perception and self- care management.12 
Importantly, symptom perception followed 
by symptom response has been described as 
Strengths and limitations of this study
 ► A strength lies in the detailed description of the 
methods, which will allow others to reproduce the 
study design.
 ► The study is based on the Medical Research Council 
Framework for the development and evaluation of 
complex interventions in health and will inform a 
subsequent trial on the intervention feasibility and 
acceptability in persons with heart failure, their in-
formal caregivers and nurses delivering the inter-
vention in a real- world setting.
 ► Internal validity is ensured by the use of valid and 
reliable instruments to collect data on outcome re-
sponsiveness as well as feasibility and acceptability 
measures.
 ► Limitations are related to the design of this pre-
test and post- test study, without a control group, 
between- group effects cannot be assessed.
 ► Further research will be needed to evaluate the ef-
fectiveness of the intervention.
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reducing the need for healthcare services and improving 
survival.7 Symptom perception has been defined as 
a process to detect physical sensations and interpret 
their meaning.12 Symptom perception is composed of 
two complementary parts: body observing and body 
analysing.13 It involves body listening, monitoring signs, 
then recognising, interpreting and labelling symptoms.12
The role of symptom perception in patient outcomes
Studies evaluating symptom perception have been asso-
ciated with mixed results14 and symptom perception 
outcomes have been reported14 such as improved general 
and physical health,15 reduced mortality,16–19 fewer HF 
decompensation events,20 decreased hospitalisation or 
emergency visits,21 22 decreased length of stay and costs,23 
better weight monitoring,24 symptom recognition25 and 
self- care management,26 27 less healthcare utilisation7 and 
shorter delays to seek care.28 29
Symptom perception remains an issue for persons with 
HF.13 In a recent literature review, symptom perception 
was described as challenging in terms of detecting phys-
ical sensations as well as interpreting the meaning of signs 
and symptoms.13 Negative consequences were escalating 
symptoms and delayed help seeking, leading to emer-
gency situations or hospitalisation.13 Symptom perception 
facilitators and barriers have been reported.13 Prior HF 
hospitalisation, HF self- care maintenance, confidence in 
symptom perception and social support have been found 
to positively influence symptom perception.13 Further, 
uncertainty about illness has been reported as a symptom 
perception facilitator,13 that is, higher illness uncertainty 
was associated with more attention to somatic changes.30 
HF- related knowledge deficits, symptom clusters (ie, the 
experience of several concurrent symptoms)31 and lack 
of tools/materials (eg, patients without a scale for weight 
monitoring)32 negatively influence symptom percep-
tion.13 One instrument, the 29- item Self- Care of HF 
Index (SCHFI) V.7.2 containing the 11- item Symptom 
Perception subscale, was found to measure symptom 
perception.15
Combining body observation, body analysis and informal 
caregivers’ involvement to support symptom perception
Body observation (ie, body listening, symptom moni-
toring) and body analysis (ie, symptom recognition, inter-
pretation and labelling) are crucial elements to combine 
to support symptom perception. According to a litera-
ture review,14 seven interventions33–39 targeting symptom 
perception in pilot studies have shown promising results 
in terms of clinical improvement of HF self- care,33 34 
decreased symptom intensity,35 number of symptoms36 
and perceived distress33 as well as better health- related 
quality of life.35 36 Another study40 focusing on symptom 
perception and symptom response pilot- tested the effi-
cacy of a similar training programme and reported greater 
absolute change compared with controls for self- care 
maintenance and confidence.40 Importantly, some inter-
ventions focused only on symptom monitoring35 37 or only 
on symptom recognition.39 Other interventions33 34 36 38 40 
including components related both to body observing 
and body analysing have been recommended to be 
further tested.14 Monitoring symptoms,41 integrating 
symptom monitoring into daily routines,41 42 under-
standing bodily sensations related with HF43 and learning 
based on past experience42 44 are recommended compo-
nents for symptom perception support interventions 
according to systematic reviews.41–44 Additionally, body 
listening and learning based on experience appear to 
be crucial in body analysing,45 which precedes symptom 
response,7 12 and should therefore be added to support 
symptom perception.
Informal caregivers need to be included in symptom 
perception support as they play a crucial role in HF 
symptom monitoring and recognition14 46 and contribute 
to HF self- care.47 They have been lacking in HF symptom 
perception research so far. It has been suggested to involve 
them in future interventions42 43 as they may improve self- 
care in older, frail and cognitively impaired persons with 
HF.2 Importantly, informal caregivers have specific needs 
related to symptom perception during all HF phases of 
illness in terms of symptom monitoring, recognition and 
management.46 Both positive and negative outcomes 
should be assessed in caregivers to fully evaluate the effect 
of involvement in HF symptom perception interven-
tions.47 Given the reciprocal relation between illness and 
family,48 and because HF can induce a burden on care-
givers,49 attention should be given to limiting that burden 
when including caregivers in symptom perception inter-
ventions. Nevertheless, no interventional study involving 
informal caregivers has reported harm to patients or 
caregivers46 and caregiver contribution to self- care main-
tenance and management did not predict burden on 
caregivers,50 suggesting benefits for both patients and 
caregivers.
The need to pilot-test an intervention supporting symptom 
perception
According to the Medical Research Council framework 
for complex interventions research methods,51 a complex 
intervention should be pilot tested for feasibility and 
acceptability before being evaluated for effectiveness.51 52 
This pilot testing aims to promote the adoption of a suit-
able intervention in a specific context, and to anticipate 
failures in the intervention that would impede its imple-
mentation.52 In the feasibility or piloting testing phase, 
uncertainties are addressed regarding methods, interven-
tion delivery and acceptability (eg, intervention fidelity, 
magnitude of effect), as well as regarding procedures 
(eg, recruitment, attrition rates, sample size determina-
tion) that are specific to an intervention and a particular 
context.52 Given the number and difficulty of different 
behaviours required by the persons delivering and 
receiving the intervention,51 supporting symptom percep-
tion is considered a complex intervention.
The literature on symptom perception is mostly descrip-
tive29 and there is a lack of fully powered interventional 
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studies with appropriate designs to assess the effective-
ness of symptom perception support.14 Except for one 
randomised controlled trial,33 40 studies34–39 were quasi- 
experimental with a pretest and post- test single group 
or to assess feasibility. Nevertheless, this evidence is suffi-
cient to inform an intervention. Few studies have tested 
the combination of support for body observing and body 
analysing. None of them have included informal care-
givers, so there is no published knowledge on the feasi-
bility or acceptability of including them, nor on their 
potential influence on the outcome of an intervention. 
Before further studying of symptom perception interven-
tion effectiveness, it is first necessary to test an interven-
tion for its feasibility in a given setting.
Study aims
The overall aim of the study is to test the feasibility, accept-
ability and outcomes responsiveness of the SYMPER-
HEART intervention supporting SYMptom PERception 
in HEART failure (SYMPERHEART).
The primary objective is to test the feasibility and 
acceptability of the SYMPERHEART intervention. The 
secondary objective is to test outcome responsiveness of 




The study is a feasibility study over a 3- month period 
with one group exposed to an intervention supporting 
symptom perception (SYMPERHEART), with a quasi- 
experimental pretest and post- test design with repeated 
measures at baseline, and after one and 3 months (ie, 
over a 3- month study period).
Intervention
The SYMPERHEART intervention (figure 1) was 
designed based on the situation- specific theory of HF 
self- care12 53 and recent literature reviews13 14 and aims 
to support symptom perception in persons with HF. 
SYMPERHEART is an evidence- informed intervention 
that targets symptom perception using both an educa-
tional and support component on body observing 
and body analysing in persons with HF and their 
informal caregivers. Its duration is 1 month40 with three 
Figure 1 The SYMPERHEART intervention combining body observing, body analysis and informal caregiver involvement to 
support symptom perception in heart failure. Symptom perception as a naturalistic decision making process.12
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face- to- face interactions delivered during this period, at 
home by homecare nurses. Nurses are previously trained 
in modules related to the intervention and supported to 
deliver it consistently. Among the nurses delivering the 
intervention, median years of being a registered nurse 
and of professional experience in homecare are, respec-
tively, 10 (IQR=9) and 4 years (IQR=6). Each interac-
tion lasts about 1 hour. All face- to- face interactions are 
provided individually for each person with HF, in the 
presence of, as far as possible, his/her informal caregiver 
with intervention components delivered to both partici-
pants together.
Prerequisites to symptom perception support
 ► The nurse informs him/herself about the situation.
The nurse assesses the person’s symptom perception 
barriers and facilitators, self- care levels and symptom clus-
ters as assessed via sociodemographic and clinical varia-
bles, HF self- care (SCHFI V.7.2; Caregiver Contribution 
to SCHFI, CC- SCHFI 2) and perception of HF symptom 
burden (Heart Failure Somatic Perception Scale, HFSPS 
V.3). The nurse reads the person’s homecare record and 
informs him/herself about the main concerns related to 
HF.
 ► HF self- care maintenance support and information 
provision.
Self- care behaviours of maintenance, symptom percep-
tion and management are often built on each other, in 
the sense that maintenance is often mastered before 
symptom perception.12 Thus, based on SCHFI V.7.2 and 
CC- SCHFI 2 baseline data, the nurse discusses the results 
of self- care maintenance with the person. The nurse high-
lights good self- care behaviours, helps reinforce self- care 
maintenance activities already mastered and seeks to iden-
tify self- care maintenance behaviours that are currently 
rather low. The nurse links the persons’ main concerns 
related with HF with self- care maintenance (eg, the will 
to remain as autonomous as possible and the benefits of 
physical activity), and suggests maintenance behaviours 
in need of improvement from a professional point of 
view. The person is provided the HF booklet of the Swiss 
Heart Foundation54 and a focus is made on discussing 
behaviours to maintain physiological stability. During this 
discussion, specific attention is paid to communicate to 
increase confidence.
Intervention components to support body observation
 ► Symptom cluster identification.
Symptom perception can be hampered by comorbidi-
ties,55 which have been shown to influence the detection 
of symptoms and make it difficult to discriminate HF 
symptoms from those of the comorbidities.13 56 Identifying 
individual symptom clusters can help attribute symptoms 
to HF40 and the results of the HFSPS V.3 are discussed 
with the person. His/her three most severe symptoms are 
identified for daily self- monitoring to guide HF symptom 
recognition.
 ► Symptom monitoring support.
Paper graphs40 for daily symptom monitoring are 
provided to persons. Persons are instructed to carry 
out daily monitoring for the severity of their three most 
severe symptoms after usual exercise (such as having a 
shower). If dyspnoea is not one of the three most severe 
symptoms, it is added to the symptoms to monitor. The 
person is instructed to monitor weight and oedema daily 
as described in the HF booklet.54 Informed by the HF 
symptom perception subscale (SCHFI V.7.2), the nurse 
discusses symptom monitoring behaviours and discusses 
how they might become embedded in the person’s daily 
routines. Persons without a digital weighing scale at home 
are provided with one. A weight monitoring graph is indi-
vidualised for each person, that is, baseline weight is docu-
mented on the graph, and upper and lower control limits 
in relation to weight gain or loss are discussed according 
an increase or loss of 2 kg over 3 days compared with the 
person’s baseline weight.2
The importance of responding to symptoms is discussed. 
Persons are informed when and how to respond to symp-
toms when experiencing any of the following alarm signs: 
weight gain or loss ≥2 kg in 3 days, sudden shortness of 
breath, strong cough during the night and orthopnea, 
dizziness, sudden leg and abdomen swelling, chest pain, 
sudden palpitations as described in the HF booklet.54
Intervention components to support body analysis
 ► Situation awareness about HF symptoms.
Given the home environment, HF symptoms are not 
triggered as previously reported.40 Instead, person recall 
is used to remember a particular symptom experience 
(eg, remembering having had shortness of breath after a 
shower or after physical exercise). In case symptoms are 
not remembered, the person walks in the presence of the 
nurse in his/her home environment, in order to help to 
recall the experience of shortness of breath.
 ► Symptom recognition and interpretation using 
guided reflection.
Symptom recognition and interpretation are supported 
through open- ended questions (table 1) in line with 
experiential learning57 using guided reflection.34 First, 
the nurse asks the person to remember a situation when 
she/he experienced HF symptom exacerbation and 
guides the person to describe the experience, with reflec-
tive observation questions. Then, the nurse supports 
abstract conceptualisation and helps to interpret HF 
symptoms from the person’s narrative. The nurse ends 
with the question preparing active experimentation and 
informs on self- care management activities2 and on how 
to respond to a possible HF symptom exacerbation when 
alarm signs are detected based on the HF booklet.54 At 
each meeting, the nurse uses these same questions related 
to symptoms experienced since the previous meeting. 
Informed by symptom perception and to support confi-
dence in symptom perception,12 13 58 the nurse supports 
related activities already performed. The nurse promotes 
self- efficacy by providing feedback on each step.59
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Intervention components involving informal caregivers
The intervention components for informal caregivers 
are similar to those delivered to persons with HF and 
are embedded in each step conducted with the person. 
Thus, intervention components involving informal care-
givers are delivered together with the components for the 
person with HF.
 ► Prerequisites to symptom perception support.
Each informal caregiver is asked to participate in every 
meeting, as far as possible. First, the informal caregiver is 
asked if she/he sees a role for him/herself relating to the 
person’s HF (‘What kind of role do you see for yourself 
in that situation?’). The informal caregiver is asked what 
kind of role she/he could imagine having to support 
symptom perception in his/her close relative (‘How do 
you/could you monitor, detect, recognize and/or inter-
pret HF symptoms together?’). The informal caregiver is 
informed about the key role she/he can have to support 
body observation and analysis in his/her relative, for 
example, in participating in weight and symptom moni-
toring activities and in supporting HF symptom recogni-
tion and interpretation of weight gain or swelling. Also, 
in the presence of the informal caregiver, the nurse asks 
the person how the informal caregiver could help him/
her. Informal caregivers are informed about www. heart-
failurematters. org web site containing specific support 
for informal caregivers.
 ► Informal caregivers’ involvement in body observation.
Informal caregivers are involved to support symptom 
perception activities related to body observation. They 
are instructed about daily self- monitoring, with informa-
tion about which HF symptoms should be monitored, 
how and how they should be reported on graphs that are 
provided. Each informal caregiver is asked to contribute 
the symptoms observed in the person, and is encouraged 
to review these symptoms with the person.
 ► Informal caregivers’ involvement in body analysis
Informal caregivers are involved to support symptom 
perception activities related to body analysis. During the 
interview using guided reflection, the nurse also uses 
guided reflection with the informal caregiver to support 
experiential learning, based on previous observations 
made by the informal caregiver, and using the same ques-
tions as those used for the persons with HF (table 1).
Coordination with usual care
During the delivery of the intervention, nurses take notes 
to document their intervention. These notes are added 
to the homecare record to inform the healthcare profes-
sionals. Importantly, when the person with HF is recruited, 
their general practitioner (GP) is informed in writing of 
the person’s enrolment in the study. The GP receives 
information about HF self- care capabilities, HF symptom 
burden based on baseline data collection, and estimated 
risks to person health based on baseline data and clinical 
judgement. The GP is asked to carry out serious adverse 
event (SAE) reporting during the study period.
Sample and setting
Three convenience samples, respectively of 30 persons 
with HF, their informal caregivers and six nurses deliv-
ering the SYMPERHEART intervention, compose the 
study sample (table 2). The recommendations about 
sample size vary between N=10–60 in pilot studies.60–62 We 
aim to include 30 persons with HF and 20–30 informal 
caregivers to address the study’s aims. Inclusion of persons 
with HF is done independently from informal caregiver 
participation.
This feasibility study is conducted in a rural region of 
Western Switzerland, in collaboration with one home- 
based service providing primary care. There, more than 
2200 persons with any type of disease receive home- based 
care, and more than 1500 of them are aged >65 years 
old.63
Recruitment procedures
Persons with HF are identified by the nurse coordi-
nator (JW) at the home- based care service using a list of 
inclusion and exclusion criteria. The nurse coordinator 
or the nurses involved in the study provide brief infor-
mation about the study existence to an eligible person 
(by providing a study leaflet) with the aim of obtaining 
permission to transfer the person’s contact information 
to the research nurse. The research nurse (GCS) contacts 
Table 1 Guided reflection questions34 57
Reflective observation questions First instructions: remember if you have already experienced that kind of symptom 
exacerbation (eg, relating to a prior HF hospitalisation)
  Describe what happened?
What did you do first? And then?
What happened at the end?
  What was good and bad about the situation?
Questions supporting abstract 
conceptualisation
What sense can you make of the situation?
What were you thinking at the time?
  What else could you have done?
Question preparing active experimentation If the situation arises again, what would you do?
HF, heart failure.
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the person per telephone to make an appointment at the 
person’s home, then confirms eligibility, provides full 
study information, answers questions, collects informed 
consent and then baseline data. The person with HF 
identifies an informal caregiver that is contacted by the 
research nurse with information on the study, and that 
supplies informed consent. Nurses are recruited by the 
home- based service managers.
Variables and measures
Primary outcome
Feasibility and acceptability are the primary outcomes 
of the study. Feasibility is measured by: time- to- recruit; 
time- to- deliver the intervention; eligibility rate and inter-
vention delivery fidelity rate (measured via a 15- point 
fidelity checklist filled by the nurse at each interaction). 
Acceptability is measured by: consent rate; retention 
rate; treatment acceptability (measured with the Treat-
ment Acceptability and Preferences measure64 adapted 
for the SYMPERHEART study including a space to add 
comments about the acceptability of the intervention); 
persons with HF and informal caregivers’ engagement in 
the SYMPERHEART intervention (measured by the rate 
of engagement in symptom and daily weight monitoring 
based on paper graph documentation; as well as by the 
rate of response to weight gain or weight loss of more 
than 2 kg in 1–3 days documented on the paper graph). 
Additionally, intervention feasibility and acceptability will 
be explored via exit interviews with the nurses, regarding 
what did and did not work regarding the delivery of the 
intervention.
Secondary outcomes
Patient- reported outcomes (PRO) and clinical outcomes 
are secondary outcomes of the study. PRO in persons 
with HF are the following: HF self- care and symptom 
perception measured with the SCHFI V.7.215 65; percep-
tion of HF symptom burden measured with the HFSPS 
V.366; as well as health status measured with the Kansas 
City Cardiomyopathy Questionnaire short version-12.67 
Clinical outcomes are HF events (ie, number of HF hospi-
talisations due to decompensation; number of deaths 
occurring during the 3 months study period); and length 
of stay in case of HF hospitalisation. Informal caregiver- 
reported outcomes are caregivers’ contribution to HF 
self- care measured with the CC- SCHFI 268 and caregivers’ 
burden measured with the Zarit Burden Interview.69 Both 
CC- SCHFI 2, SCHFI V.7.2 and HFSPS V.3 have been trans-
lated from English to French and German (for Switzer-
land) according to state- of the art recommendations for 
linguistic validation of PROs.70
Other variables
For persons with HF
Sociodemographic variables: age, sex, level of education, 
living alone or with someone, received social support, 
religion, race. Clinical variables: date of HF diagnosis, 
severity of HF via the New York Heart Association func-
tional class, previous HF hospitalisation, comorbid condi-
tions measured via the Charlson Comorbidity Index,71 
cognitive impairment as recorded in homecare records, 
depressive symptomatology and screening via the Patient 
Health Questionnaire-2.72 Other variables: confidence in 
symptom perception, via two items of the Self- care confi-
dence subscale73 and having a digital scale at home.
For informal caregivers
Age, sex, education level, living situation, received social 
support, nature of relationship with the person with HF, 
nature of living situation with the person, religion, race. 
Table 2 Participants inclusion criteria
Inclusion criteria Exclusion criteria
Persons with HF  ► Adults ≥18 years old
 ► Confirmed HF diagnostic
 ► NYHA class II–IV
 ► Speaking French or German
 ► Receiving home- based care and living at home
 ► Providing written informed consent to participate
 ► Suffering from immediately life threatening or 
terminal illness.
 ► Clinical instability requiring hospitalisation.
 ► Already enrolled in an interventional study 
supporting HF self- care
 ► Subject to cognitive impairment that would 
preclude written informed consent.
Informal caregivers  ► Adults ≥18 years old.
 ► Identified by the participating HF person as an 
informal caregiver.
 ► Living with the person with HF or having at least 
weekly contact.
 ► Speaking French or German.
 ► Providing written informed consent to participate.
 ► Cognitive impairment that would preclude 
written informed consent.
 ► Suffering from immediately life threatening or 
terminal illness.
 ► Refusal by the person with HF to involve an 
informal caregiver in the study.
Nurses  ► Registered/diploma nurses delivering the intervention.
 ► Working in the study setting’s homecare site.
 ► Fluent in French or German.
 ► Being designated by the homecare nurse manager.
 ► Not having attended to the preparation 
sessions of the intervention.
HF, heart failure; NYHA, New York Heart Association functional class.
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Also, caregiver self- efficacy related to symptom moni-
toring and recognition is collected with two items of the 
Caregiver Self- efficacy in Contribution to Self- care Scale.73
For nurses
Age, sex, professional experience, professional experi-
ence in home care.
Data collection
Data collection points (figure 2) are at research enrol-
ment (baseline), at the end of the 1- month intervention 
(T1), and 2 months later (T2). Sociodemographic and 
clinical data regarding persons with HF are retrieved 
from homecare records and recorded in a case report 
form by the research nurse at study enrolment. Inter-
views are conducted to collect variables not retrievable 
in the homecare records. PRO and caregiver- reported 
outcomes are collected at T0, T1 and T2 through partici-
pant self- report via paper questionnaires, including treat-
ment acceptability at T1. Persons are asked to send a copy 
of the pressure- sensitive paper monitoring graph at T1. 
In case of no response or if baseline data suggest that 
help is needed to fill in the questionnaire, the research 
nurse contacts the participants to help complete the 
questionnaire. HF events and SAE are collected by the 
research nurse via homecare records, prospectively for 
the 3- month study period and through SAE forms. At the 
end of the intervention, we collect variables from nurses 
(table 3).
Analysis
Descriptive statistics will be used to describe the sample 
with measures as appropriate of frequency or central 
tendency (mean, SD or median, IQR if not normally 
distributed), ordinal (median, IQR) and nominal vari-
ables (mode, percentages) as appropriate.
To describe intervention feasibility, the total time neces-
sary for recruitment and delivery to all participants will be 
reported, as well as the total number of persons eligible. 
The intervention delivery fidelity rate will be described 
with the proportion of each intervention component 
based on fidelity checklist, as well as an overall percentage 
of intervention components delivered to each participant.
To describe intervention acceptability, consenting rate 
and retention rate will be reported. Treatment accept-
ability will be reported with median and IQR for each item 
of the treatment acceptability measure. The engagement 
of persons with HF and informal caregivers in symptom 
and daily weight monitoring will be reported.
Intervention feasibility and acceptability will be deter-
mined based on the description of each of the elements 
above. No cut- off for feasibility and acceptability will be 
defined beforehand.
The SYMPERHEART outcome responsiveness for 
persons with HF will be described as the mean absolute 
change between preintervention and postintervention 
(baseline and T1; baseline and T2) for HF self- care 
(mean absolute change for self- care maintenance, 
symptom perception and management), mean absolute 
change in symptom burden and mean absolute change 
for health status. Effect sizes will be estimated using 
Cohen’s d or correlation coefficients74 for HF self- care, 
symptom burden as well as health status. For each of the 
PRO, a power analysis with an assumed alpha=0.05 and 
beta=0.80 will estimate the necessary sample size for a 
further effectiveness study. For clinical outcomes, the 
total number of HF events will be reported, as well as 
length of stay for HF hospitalisation.
The SYMPERHEART outcome responsiveness for 
informal caregivers will be described as the mean abso-
lute change between pre and post intervention (base-
line and T1; baseline and T2) for caregiver contribution 
Figure 2 Graph of the study period. Each person and caregiver are enrolled for 3 months from the day of study enrolment until 
the last follow- up (+90 days). They are exposed to the SYMPERHEART intervention during 1 month following enrolment.
 on A











pen: first published as 10.1136/bm




8 Santos GC, et al. BMJ Open 2021;11:e052208. doi:10.1136/bmjopen-2021-052208
Open access 
of self- care of HF and caregiver burden. Effect sizes will 
be estimated using the same calculations as described 
above.
The SPSS V.23 (IBM SPSS Statistics) will be used for 
analysis, as well as SAS V.9.4 (SAS institute).
Ethics and dissemination
Ethical approval has been obtained from the Human 
Research Ethics Committee of the Canton of Vaud, 
Switzerland, on 7 October 2020 (ref. 2020–01820). 
The study is conducted according to the Declaration 
of Helsinki. Written informed consent is obtained from 
persons with HF and informal caregivers; oral informed 
consent is obtained from homecare nurses.
We consider being included in this study as involving 
a minimal risk; this viewpoint has been confirmed by 
the aforementioned Ethics Committee. All persons 
with HF benefit from usual medical and nursing 
care independently from their participation in the 
study. During the intervention and data collection, 
adequate protective measures are taken in line with 
the COVID-19 pandemic situation. Given that persons 
with symptomatic HF are a vulnerable population 
regarding COVID-19,75 and given that technology- 
based interventions are not always feasible for older 
citizens,76 we consider the risk of face- to- face inter-
actions with persons with HF under use of adequate 
protective measures to be balanced77 with regard to 
the urgent need to support symptom perception in 
persons with HF.
Results will be published in peer- reviewed journals 
as well as professional journals. They will also be made 
known through local conferences and research semi-
nars, national and international scientific congresses, 
and through direct and indirect contacts with clini-
cians, public health managers and other healthcare 
professionals. Results will be integrated into nursing 
education.
Patient and public involvement
Patients were not involved in developing the study. 
However, they are asked to assess the acceptability of 
the intervention via the adapted Treatment Accept-
ability and Preferences measure.
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